FrancophonIA/ELRC3.0 huggingface dataset:
English: The active ingredient in Halimatoz, adalimumab, is a monoclonal antibody.
Slovenian: Učinkovina v zdravilu Halimatoz, adalimumab, je monoklonsko protitelo.
English: • If you have an infection, including long-term or localised infection (for example leg ulcer), consult your doctor before starting Halimatoz.
Slovenian: • Če imate kakšno okužbo, vključno z dolgotrajno ali omejeno okužbo (npr. razjedo na nogi), se pred uporabo zdravila Halimatoz posvetujte s svojim zdravnikom.
English: If a patient develops symptoms suggestive of a lupus-like syndrome following treatment with Halimatoz and is positive for antibodies against double-stranded DNA, further treatment with Halimatoz should not be given (see section 4.8).
Slovenian: Če se bolniku po zdravljenju z zdravilom Halimatoz pojavijo simptomi, ki nakazujejo lupusu podobni sindrom, in ima pozitivna protitelesa proti dvojnoverižni DNA, zdravljenja z zdravilom Halimatoz ne sme nadaljevati (glejte poglavje 4.8).
English: Thus additional caution should be exercised in considering Halimatoz treatment of these patients (see section 4.8).
Slovenian: Torej je potrebna dodatna previdnost, kadar razmišljamo o zdravljenju z zdravilom Halimatoz pri teh bolnikih (glejte poglavje 4.8).
English: Tell your doctor if you are taking azathioprine or mercaptopurine with Halimatoz.
Slovenian: Povejte zdravniku, če prejemate azatioprin ali merkaptopurin sočasno z zdravilom Halimatoz.
English: If an anaphylactic reaction or other serious allergic reaction occurs, administration of Halimatoz should be discontinued immediately and appropriate therapy initiated.
Slovenian: Če se pojavi anafilaktična reakcija ali kakšna druga resna alergijska reakcija, je treba uporabo zdravila Halimatoz nemudoma prekiniti in uvesti ustrezno zdravljenje.
English: A risk for the development of hepatosplenic T-cell lymphoma in patients treated with Halimatoz cannot be excluded (see section 4.8).
Slovenian: Tveganja za razvoj hepatospleničnega limfoma celic T pri bolnikih, ki dobivajo zdravilo Halimatoz, ni mogoče izključiti (glejte poglavje 4.8).
English: Patients treated with Halimatoz should be given the Patient Reminder Card.
Slovenian: Bolniki, ki se zdravijo z zdravilom Halimatoz, morajo dobiti opozorilno kartico za bolnika.
English: Halimatoz can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.
Slovenian: Zdravilo Halimatoz je mogoče uporabiti kot monoterapijo v primeru intolerance za metotreksat ali kadar nadaljnje zdravljenje z metotreksatom ni primerno.
English: Should treatment be interrupted, Halimatoz may be re-introduced as appropriate.
Slovenian: Če je treba zdravljenje prekiniti, je možno zdravljenje z zdravilom Halimatoz znova uvesti, kakor je primerno.
English: You should continue to inject Halimatoz for as long as your doctor has told you.
Slovenian: Nadaljevati morate z injiciranjem zdravila Halimatoz tako dolgo, kot vam je naročil zdravnik.
English: Halimatoz is used to treat polyarticular juvenile idiopathic arthritis in children and adolescents aged 2 to 17 years and enthesitis-related arthritis in children and adolescents aged 6 to 17 years.
Slovenian: Zdravilo Halimatoz se uporablja za zdravljenje poliartikularnega juvenilnega idiopatskega artritisa pri otrocih in mladostnikih, starih 2 do 17 let in artritisa, povezanega z entezitisom pri otrocih in mladostnikih starih od 6 do 17 let.
English: Halimatoz is used to treat Crohn's disease in adults and children aged 6 to 17 years.
Slovenian: Zdravilo Halimatoz se uporablja za zdravljenje Crohnove bolezni pri odraslih in otrocih, starih od 6 do 17 let.
English: If you use more Halimatoz than you should
Slovenian: Če ste uporabili večji odmerek zdravila Halimatoz, kot bi smeli
English: Halimatoz contains the active substance adalimumab, a medicine that acts on your body's immune (defence) system.
Slovenian: Zdravilo Halimatoz vsebuje učinkovino adalimumab, ki deluje na imunski sistem (obrambni mehanizem) telesa.
English: What you need to know before you use Halimatoz Do not use Halimatoz
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo Halimatoz Ne uporabljajte zdravila Halimatoz
English: In non-infectious uveitis, corticosteroids or other medicines that influence the immune system may be continued while using Halimatoz.
Slovenian: V primeru neinfekcijskega uveitisa se kortikosteroidi ali druga zdravila, ki zavirajo imunski sistem lahko še nadalje uporabljajo ob uporabi zdravila Halimatoz.
English: Halimatoz can also be used to treat severe, active and progressive rheumatoid arthritis without previous methotrexate treatment.
Slovenian: Zdravilo Halimatoz je mogoče uporabljati tudi za zdravljenje hudega, aktivnega in napredujočega revmatoidnega artritisa brez predhodnega zdravljenja z metotreksatom.
English: What Halimatoz is and what it is used for What you need to know before you use Halimatoz How to use Halimatoz
Slovenian: Kaj je zdravilo Halimatoz in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Halimatoz Kako uporabljati zdravilo Halimatoz
English: Taking these results into consideration, Halimatoz is recommended for use in combination with MTX and for use as monotherapy in patients for whom MTX use is not appropriate (see section 4.2).
Slovenian: Z upoštevanjem teh ugotovitev je zdravilo Halimatoz priporočljivo uporabljati v kombinaciji z metotreksatom, kot monoterapijo pa pri bolnikih, za katere uporaba metotreksata ni primerna (glejte poglavje 4.2).
English: • When needed (for example when you are travelling), Halimatoz may be stored at room temperature (up to 25°C) for a maximum period of 14 days - be sure to protect it from light.
Slovenian: • Če je potrebno (na primer kadar potujete), lahko zdravilo Halimatoz hranite pri sobni temperaturi (do 25 °C) za največ 14 dni - zagotovite, da bo zaščiteno pred svetlobo.
English: Alternatively, if a patient has stopped Halimatoz and signs and symptoms of disease recur, Halimatoz may be re-administered.
Slovenian: Če bolnik neha uporabljati zdravilo Halimatoz, pa se znaki in simptomi bolezni ponovijo, je mogoče zdravilo Halimatoz znova uvesti.
English: Halimatoz 40 mg solution for injection in pre-filled pen EU/1/18/1288/004
Slovenian: Halimatoz 40 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku EU/1/18/1288/004
English: Halimatoz is also used to treat severe plaque psoriasis in children and adolescents aged 4 to 17 years for whom medicines applied to the skin and treatment with UV light have either not worked very well or are not suitable.
Slovenian: Zdravilo Halimatoz se uporablja tudi za zdravljenje hude luskavice v plakih pri otrocih in mladostnikih, starih od 4 do 17 let, pri katerih zdravila, ki se nanašajo na kožo, in zdravljenje z UV-svetlobo niso dovolj dobro delovali ali pa niso primerni.
English: A single Halimatoz pre-filled syringe / pre-filled pen may be stored at temperatures up to a maximum of 25°C for a period of up to 14 days.
Slovenian: Posamezna napolnjena injekcijska brizga ali napolnjen injekcijski peresnik zdravila Halimatoz se lahko shranjuje pri temperaturi do največ 25 ºC za obdobje do 14 dni.
English: Halimatoz may have a minor influence on the ability to drive and use machines.
Slovenian: Zdravilo Halimatoz ima lahko blag vpliv na sposobnost vožnje in upravljanja strojev.
English: Patients must therefore be monitored closely for infections, including tuberculosis, before, during and after treatment with Halimatoz.
Slovenian: Bolnike je zato treba pred, med in po zdravljenju z zdravilom Halimatoz natančno kontrolirati glede okužb, vključno s tuberkulozo.
English: Patients who develop a new infection while undergoing treatment with Halimatoz should be monitored closely and undergo a complete diagnostic evaluation.
Slovenian: Bolnike, pri katerih se med zdravljenjem z zdravilom Halimatoz pojavi nova okužba, je treba natančno nadzirati in opraviti morajo popolno diagnostično obravnavo.
English: Halimatoz can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate (for the efficacy in monotherapy see section 5.1).
Slovenian: Zdravilo Halimatoz je mogoče uporabiti kot monoterapijo v primeru intolerance za metotreksat ali kadar nadaljnje zdravljenje z metotreksatom ni primerno (za učinkovitost monoterapije glejte poglavje 5.1).
English: Women of childbearing potential should consider the use of adequate contraception to prevent pregnancy and continue its use for at least five months after the last Halimatoz treatment.
Slovenian: Ženske v rodni dobi morajo premisliti o uporabi ustrezne kontracepcijske zaščite za preprečitev nosečnosti in z njo nadaljevati vsaj še pet mesecev po zadnjem zdravljenju z zdravilom Halimatoz.
English: Treatment with Halimatoz may result in the formation of autoimmune antibodies.
Slovenian: Zdravljenje z zdravilom Halimatoz lahko povzroči nastanek avtoimunskih protiteles.
English: If you have mild heart failure and you are being treated with Halimatoz, your heart failure status must be closely monitored by your doctor.
Slovenian: Če imate blago srčno popuščanje in se zdravite z zdravilom Halimatoz, mora zdravnik natančno nadzorovati stanje vašega srčnega popuščanja.
English: Patients should be tested for HBV infection before initiating treatment with Halimatoz.
Slovenian: Bolnike je treba pred začetkom zdravljenja z zdravilom Halimatoz testirati na okužbo s HBV.
English: Halimatoz can be taken together with methotrexate or certain disease-modifying anti-rheumatic agents (sulfasalazine, hydroxychloroquine, leflunomide and injectable gold preparations), corticosteroids or pain medications including non-steroidal anti-inflammatory drugs (NSAIDs).
Slovenian: Zdravilo Halimatoz se lahko uporablja skupaj z metotreksatom ali nekaterimi imunomodulirajočimi antirevmatičnimi zdravili (sulfasalazinom, hidroksiklorokinom, leflunomidom in pripravki zlata za injiciranje), kortikosteroidi in zdravili proti bolečinam, vključno z nesteroidnimi protivnetnimi zdravili.
English: After proper training in injection technique, patients may self-inject with Halimatoz if their physician determines that it is appropriate and with medical follow-up as necessary.
Slovenian: Bolniki, ki se naučijo pravilnega postopka injiciranja, si zdravilo Halimatoz lahko injicirajo sami, če zdravnik presodi, da je to primerno, in je zagotovljeno ustrezno medicinsko spremljanje.
English: Halimatoz may have a minor influence on your ability to drive, cycle or use machines.
Slovenian: Zdravilo Halimatoz ima lahko blag vpliv na sposobnost vožnje, kolesarjenja ali upravljanja strojev.
English: All patients should be advised to seek immediate medical attention if they develop signs and symptoms suggestive of blood dyscrasias (e.g. persistent fever, bruising, bleeding, pallor) while on Halimatoz.
Slovenian: Vsem bolnikom je treba naročiti, naj nemudoma poiščejo zdravniško pomoč, če se jim med uporabo zdravila Halimatoz pojavijo znaki ali simptomi krvnih diskrazij (npr. trajno zvišana telesna temperatura, podplutbe, krvavitve, bledica).
English: 5 How to store Halimatoz Contents of the pack and other information Instructions for use
Slovenian: 5 Shranjevanje zdravila Halimatoz Vsebina pakiranja in dodatne informacije Navodila za uporabo
English: Should treatment be interrupted, Halimatoz 40 mg every week or 80 mg every other week may be reintroduced (see section 5.1).
Slovenian: Če je potrebno z zdravljenjem prekiniti, lahko ponovno uvedete zdravljenje z zdravilom Halimatoz z odmerkom 40 mg vsak teden ali 80 mg vsak drugi teden (glejte poglavje 5.1).
English: • inject Halimatoz 15-30 minutes after taking it out of the refrigerator for a more comfortable injection.
Slovenian: • zdravilo Halimatoz injicirate 15-30 minut po tem, ko ste ga vzeli iz hladilnika, da bo občutek pri injiciranju prijetnejši.
English: Halimatoz is a biosimilar medicinal product.
Slovenian: Zdravilo Halimatoz je podobno biološko zdravilo.
English: It is recommended that, if possible, children be given all the scheduled vaccinations for their age before they start treatment with Halimatoz.
Slovenian: Za otroke je priporočljivo, da pred začetkom zdravljenja z zdravilom Halimatoz prejmejo vsa cepljenja, predvidena za njihovo starost, če je le mogoče.
English: • If you have or develop demyelinating disease (a disease that affects the insulating layer around the nerves, such as multiple sclerosis), your doctor will decide if you should receive or continue to receive Halimatoz.
Slovenian: Demielinizirajoča bolezen • Če imate ali pa se pri vas razvija demielinizirajoča bolezen (bolezen, ki prizadene izolacijsko plast okrog živcev, kot je multipla skleroza), bo zdravnik presodil, ali lahko dobivate zdravilo Halimatoz.
English: Physicians should exercise caution when considering the use of Halimatoz in patients with a history of recurring infection or with underlying conditions which may predispose patients to infections, including the use of concomitant immunosuppressive medications.
Slovenian: Pri odločanju za uporabo zdravila Halimatoz je potrebna previdnost pri bolnikih z anamnezo ponavljajoče se okužbe ali z osnovnimi boleznimi, ki lahko zvečajo nagnjenost k okužbam, vključno s sočasno uporabljenimi imunosupresivnimi zdravili.
English: Consequently, Halimatoz can be used during breastfeeding..
Slovenian: Posledično se zdravilo Halimatoz lahko uporablja med dojenjem.
English: Halimatoz is used to treat
Slovenian: Zdravilo Halimatoz se uporablja za zdravljenje
English: Halimatoz is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy.
Slovenian: Zdravilo Halimatoz je indicirano za zdravljenje zmerne do hude kronične psoriaze v plakih pri odraslih bolnikih, ki so kandidati za sistemsko zdravljenje.
English: In rheumatoid arthritis, methotrexate is continued while using Halimatoz.
Slovenian: Pri revmatoidnem artritisu se uporaba metotreksata med uporabo zdravila Halimatoz nadaljuje.
English: Halimatoz is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults and adolescents from 12 years of age with an inadequate response to conventional systemic HS therapy (see sections 5.1 and 5.2).
Slovenian: Zdravilo Halimatoz je indicirano za zdravljenje aktivne, zmerne do hude oblike hidradenitis suppurativa (acne inversa) pri odraslih in mladostnikih, starejših od 12 let, ki se ne odzovejo zadovoljivo na konvencionalno sistemsko HS zdravljenje (glejte poglavji 5.1 in 5.2).
English: Mood alterations (including depression), anxiety, insomnia
Slovenian: Psihiatrične motnje pogosti spremembe razpoloženja (vključno z depresijo), anksioznost,
English: Prescribers should exercise caution in considering the use of Halimatoz in patients with pre-existing or recent-onset central or peripheral nervous system demyelinating disorders; discontinuation of Halimatoz should be considered if any of these disorders develop.
Slovenian: Pri odločanju za uporabo zdravila Halimatoz pri bolnikih z že prej obstoječimi ali nedavno nastalimi demielinizirajočimi boleznimi osrednjega ali perifernega živčevja je potrebna previdnost; če se razvije katera od teh bolezni, je treba razmisliti o prenehanju zdravljenja z zdravilom Halimatoz.
English: A patient who requires surgery while on Halimatoz should be closely monitored for infections, and appropriate actions should be taken.
Slovenian: Bolnika, ki med zdravljenjem z zdravilom Halimatoz potrebuje operacijo, je treba natančno nadzirati glede okužb in ustrezno ukrepati.
English: Halimatoz in combination with methotrexate is indicated for the treatment of active polyarticular juvenile idiopathic arthritis, in patients from the age of 2 years who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs).
Slovenian: Zdravilo Halimatoz je v kombinaciji z metotreksatom indicirano za zdravljenje aktivnega poliartikularnega juvenilnega idiopatskega artritisa pri bolnikih od 2. leta starosti, ki se ne odzovejo ustrezno na eno ali več imunomodulirajočih antirevmatičnih zdravil.
English: • Halimatoz can be used during breast-feeding.
Slovenian: • Zdravilo Halimatoz se lahko uporablja med dojenjem.
English: - Your doctor will also give you a Patient Reminder Card, which contains important safety information that you need to be aware of before you are given Halimatoz and during treatment with Halimatoz.
Slovenian: Ta vsebuje pomembne varnostne informacije, s katerimi morate biti seznanjeni, preden prejmete zdravilo Halimatoz in med zdravljenjem z njim.
English: Halimatoz is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS but with objective signs of inflammation by elevated CRP and / or MRI, who have had an inadequate response to, or are intolerant to nonsteroidal anti-inflammatory drugs.
Slovenian: Zdravilo Halimatoz je indicirano za zdravljenje odraslih s hudim aksialnim spondiloartritisom brez radiografskega dokaza za AS, toda z objektivnimi znaki vnetja s povišanimi CRP in/ali MRI, ki so nezadostno reagirali na ali ne prenašajo nesteroidnih protivnetnih zdravil.
English: If these medicines do not work well enough, you will be given Halimatoz.
Slovenian: Če ta zdravila ne bodo dovolj dobro delovala, boste dobili zdravilo Halimatoz.
English: What Halimatoz looks like and contents of the pack
Slovenian: Izgled zdravila Halimatoz in vsebina pakiranja
English: Administration of Halimatoz should be discontinued if a patient develops a new serious infection or sepsis, and appropriate antimicrobial or antifungal therapy should be initiated until the infection is controlled.
Slovenian: Če se bolniku pojavi nova resna okužba ali sepsa, je treba uporabo zdravila Halimatoz prekiniti in uvesti ustrezno protimikrobno ali protimikotično zdravljenje, dokler okužba ni obvladana.
English: If your doctor considers that methotrexate is inappropriate, Halimatoz can be given alone.
Slovenian: Če vaš zdravnik presodi, da metotreksat ni primeren, lahko zdravilo Halimatoz dobivate samo.
English: Halimatoz is indicated for the treatment of severe chronic plaque psoriasis in children and adolescents from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapies.
Slovenian: Zdravilo Halimatoz je indicirano za zdravljenje hude psoriaze v plakih pri otrocih in mladostnikih od 4. leta starosti, ki so se neustrezno odzvali na ali niso ustrezni kandidati za topikalno zdravljenje in fototerapije.
English: The decision to stop using Halimatoz should be discussed with your doctor.
Slovenian: Če ste prenehali uporabljati zdravilo Halimatoz O odločitvi, da bi prenehali uporabljati zdravilo Halimatoz, se morate posvetovati s svojim zdravnikom.
English: If your doctor determines that methotrexate is inappropriate, Halimatoz can be given alone.
Slovenian: Če vaš zdravnik ugotovi, da metotreksat ni primeren, lahko zdravilo Halimatoz dobivate samo.
English: Neurologic evaluation should be performed in patients with noninfectious intermediate uveitis prior to the initiation of Halimatoz therapy and regularly during treatment to assess for pre-existing or developing central demyelinating disorders.
Slovenian: Pri bolnikih z neinfekcijskim intermediarnim uveitisom je treba pred začetkom zdravljenja z zdravilom Halimatoz in redno med zdravljenjem opravljati nevrološko oceno, da se oceni že obstoječe ali razvijajoče se demielinizirajoče bolezni osrednjega živčevja.
English: Usually, Halimatoz is used with methotrexate.
Slovenian: Zdravilo Halimatoz ponavadi uporabljamo z metotreksatom.
English: If you forget to use Halimatoz
Slovenian: Če ste pozabili uporabiti zdravilo Halimatoz
English: Halimatoz is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate.
Slovenian: Zdravilo Halimatoz je indicirano za zdravljenje neinfekcijskega intermediarnega, posteriornega uveitisa in panuveitisa pri odraslih bolnikih, ki se niso zadostno odzvali na zdravljenje s kortikosteroidi, pri bolnikih s potrebo po zmanjšani uporabi kortikosteroidov ali pri bolnikih, pri katerih je zdravljenje s kortikosteroidi neprimerno.
English: • You should consider the use of adequate contraception to prevent pregnancy and continue its use for at least 5 months after the last Halimatoz treatment.
Slovenian: Nosečnost in dojenje • Premisliti morate o uporabi ustrezne kontracepcijske zaščite za preprečitev nosečnosti in z njo nadaljevati vsaj še 5 mesecev po zadnjem zdravljenju z zdravilom Halimatoz.
English: • Do not give Halimatoz to children with paediatric Crohn's disease below the age of 6 years.
Slovenian: • Zdravila Halimatoz ne smete dati otroku s Crohnovo boleznijo, če je star manj kot 6 let.
English: Halimatoz is intended for the treatment of the following inflammatory diseases:
Slovenian: Zdravilo Halimatoz je namenjeno za zdravljenje vnetnih bolezni, opisanih spodaj:
English: Halimatoz is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate.
Slovenian: Zdravilo Halimatoz je indicirano za zdravljenje aktivnega in napredujočega psoriatičnega artritisa pri odraslih, če odziv na predhodno zdravljenje z imunomodulirajočimi antirevmatiki ni bil ustrezen.
English: Halimatoz works by reducing this inflammation.
Slovenian: Zdravilo Halimatoz deluje tako, da zmanjša tako vnetje.
English: Antibiotics may be continued during treatment with Halimatoz if necessary.
Slovenian: Med zdravljenjem z zdravilom Halimatoz lahko nadaljujete z antibiotičnim zdravljenjem, če je potrebno.
English: • intestinal infections (including gastroenteritis);
Slovenian: črevesne okužbe (vključno z virusnim gastroenteritisom),
English: Methotrexate should be continued during treatment with Halimatoz.
Slovenian: Med zdravljenjem z zdravilom Halimatoz je treba še naprej uporabljati metotreksat.
English: Halimatoz is injected under the skin (subcutaneous use).
Slovenian: Zdravilo Halimatoz se injicira pod kožo (subkutana uporaba).
English: Halimatoz dose for patients with polyarticular juvenile idiopathic arthritis
Slovenian: Odmerjanje zdravila Halimatoz pri bolnikih s poliartikularnim juvenilnim idiopatskim artritisom
English: • that Halimatoz treatment may increase the potential risks of o infections, including tuberculosis o cancer o nervous system problems o vaccinations
Slovenian: • obvestilo, da lahko zdravljenje z zdravilom Halimatoz poveča tveganje o okužb, vključno s tuberkulozo; o raka;
English: The Halimatoz 40 mg pre-filled syringe should not be used in children or adolescents weighing less than 40 kg with Crohn's disease, since it is not possible to administer doses less than 40 mg.
Slovenian: Zdravila Halimatoz 40 mg napolnjena injekcijska brizga ne smete uporabljati pri otrocih ali mladostnikih s Crohnovo boleznijo, ki tehtajo manj kot 40 kg, saj ni mogoče dati odmerka, manjšega od 40 mg.
English: Halimatoz dose for paediatric patients with Crohn's disease
Slovenian: Odmerjanje zdravila Halimatoz pri pediatričnih bolnikih s Crohnovo boleznijo
English: * Note: Halimatoz is currently only available as 40 mg pre-filled syringe and 40 mg pre-filled pen.
Slovenian: * Opomba: Zdravilo Halimatoz je trenutno na voljo samo v 40 mg napolnjeni injekcijski brizgi in 40 mg napolnjenem injekcijskem peresniku.
English: For patients who develop the signs and symptoms such as fever, malaise, weight loss, sweats, cough, dyspnoea, and / or pulmonary infiltrates or other serious systemic illness with or without concomitant shock an invasive fungal infection should be suspected and administration of Halimatoz should be promptly discontinued.
Slovenian: Če se bolniku pojavijo znaki ali simptomi, kot so npr. zvišana telesna temperatura, splošno slabo počutje, hujšanje, znojenje, kašelj, dispneja in/ali pljučni infiltrati ali druga sistemska bolezen (s spremljajočim šokom ali brez njega), je treba posumiti na invazivno glivično okužbo.